BTG2 and prostate carcinoma: Given that our previous study has shown that ectopic overexpression of BTG2 in PC-3 cells could inhibit cancer cell proliferation13, to further verify BTG2 role in cisplatin-induced inhibition on prostate cancer proliferation, we knocked down BTG2 expression by shRNA in LNCaP cells.